Analysis of the functional contributions of Asn233 in metallo-β- lactamase IMP-1

Antimicrobial Agents and Chemotherapy

Volumn 55, Issue 12, 2011, Pages 5696-5702

  Brown, Nicholas G ^a   Horton, Lori B ^a   Huang, Wanzhi ^a   Vongpunsawad, Sompong ^a   Palzkill, Timothy ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAM ANTIBIOTIC; CARBAPENEM; CEFALOTIN; CEFOTAXIME; CEPHALOSPORIN DERIVATIVE; IMIPENEM; IMP 1 PROTEIN; METALLO BETA LACTAMASE; PENICILLIN G; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANTIBIOTIC SENSITIVITY; ARTICLE; ENZYME ANALYSIS; ESCHERICHIA COLI; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SITE DIRECTED MUTAGENESIS; WILD TYPE;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANTI-BACTERIAL AGENTS; ASPARAGINE; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; BETA-LACTAMS; ESCHERICHIA COLI; KINETICS; MICROBIAL SENSITIVITY TESTS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED;

EID: 81555201969     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00340-11     Document Type: Article

References (47)

1. Amann, E., J. Brosius, and M. Ptashne. 1983. Vectors bearing a hybrid trp-lac promoter useful for regulated expression of cloned genes in Escherichia coli. Gene 25:167-178. (Pubitemid 14204643)
2. Bebrone, C. 2007. Metallo-beta-lactamases (classification, activity, genetic organization, structure, zinc coordination) and their superfamily. Biochem. Pharmacol. 74:1686-1701.
3. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
4. Brent, R., and M. Ptashne. 1981. Mechanism of action of the lexA gene product. Proc. Natl. Acad. Sci. U. S. A. 78:4204-4208.
5. Brown, N. G., J. M. Pennington, W. Huang, T. Ayvaz, and T. Palzkill. 2010. Multiple global suppressors of protein stability defects facilitate the evolution of extended-spectrum TEM beta-lactamases. J. Mol. Biol. 404:832-846.
6. Bullock, W. O., J. M. Fernandez, and J. M. Short. 1987. XL1-Blue: a high efficiency plasmid transforming recA Escherichia coli strain with beta-galactosidase selection. Biotechniques 5:376-379.
7. Bush, K. 2010. Alarming beta-lactamase-mediated resistance in multidrugresistant Enterobacteriaceae. Curr. Opin. Microbiol. 13:558-564.
8. Bush, K., and G. A. Jacoby. 2010. Updated functional classification of betalactamases. Antimicrob. Agents Chemother. 54:969-976.
9. Bush, K., G. A. Jacoby, and A. A. Medeiros. 1995. A functional classification scheme for beta-lactamases and its correlation with molecular structure. Antimicrob. Agents Chemother. 39:1211-1233.
10. Butterworth, D., M. Cole, G. Hanscomb, and G. N. Rolinson. 1979. Olivanic acids, a family of beta-lactam antibiotics with beta-lactamase inhibitory properties produced by Streptomyces species. I. Detection, properties and fermentation studies. J. Antibiot. (Tokyo) 32:287-294. (Pubitemid 9189889)
11. Carenbauer, A. L., J. D. Garrity, G. Periyannan, R. B. Yates, and M. W. Crowder. 2002. Probing substrate binding to metallo-beta-lactamase L1 from Stenotrophomonas maltophilia by using site-directed mutagenesis. BMC Biochem. 3:4.
12. Chenna, R., et al. 2003. Multiple sequence alignment with the Clustal series of programs. Nucleic Acids Res. 31:3497-3500. (Pubitemid 37442184)
13. Concha, N. O., et al. 2000. Crystal structure of the IMP-1 metallo betalactamase from Pseudomonas aeruginosa and its complex with a mercaptocarboxylate inhibitor: binding determinants of a potent, broad-spectrum inhibitor. Biochemistry 39:4288-4298. (Pubitemid 30212644)
14. Crowder, M. W. 2006. Metallo-β-lactamases: novel weaponry for antibiotic resistance in bacteria. Acc. Chem. Res. 39:721-728.
15. Drawz, S. M., and R. A. Bonomo. 2010. Three decades of beta-lactamase inhibitors. Clin. Microbiol. Rev. 23:160-201.
16. Galleni, M., et al. 2001. Standard numbering scheme for class B betalactamases. Antimicrob. Agents Chemother. 45:660-663. (Pubitemid 32182004)
17. Garau, G., et al. 2005. A metallo-beta-lactamase enzyme in action: crystal structures of the monozinc carbapenemase CphA and its complex with biapenem. J. Mol. Biol. 345:785-795. (Pubitemid 39600934)
18. Goldstein, E. J. 2011. Beyond the target pathogen: ecological effects of the hospital formulary. Curr. Opin. Infect. Dis. 24(Suppl. 1):S21-S31.
19. Haruta, S., et al. 2000. Functional analysis of the active site of a metallobeta- lactamase proliferating in Japan. Antimicrob. Agents Chemother. 44: 2304-2309. (Pubitemid 30650872)
20. Haruta, S., E. T. Yamamoto, Y. Eriguchi, and T. Sawai. 2001. Characterization of the active-site residues asparagine 167 and lysine 161 of the IMP-1 metallo beta-lactamase. FEMS Microbiol. Lett. 197:85-89. (Pubitemid 32245756)
21. Ho, S. N., H. D. Hunt, R. M. Horton, J. K. Pullen, and L. R. Pease. 1989. Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 77:51-59. (Pubitemid 19125653)
22. Ito, H., et al. 1995. Plasmid-mediated dissemination of the metallo-betalactamase gene blaIMP among clinically isolated strains of Serratia marcescens. Antimicrob. Agents Chemother. 39:824-829.
23. Kahan, J. S., et al. 1979. Thienamycin, a new beta-lactam antibiotic. I. Discovery, taxonomy, isolation and physical properties. J. Antibiot. (Tokyo) 32:1-12. (Pubitemid 9104065)
24. Lauretti, L., et al. 1999. Cloning and characterization of blaVIM, a new integron-borne metallo-beta-lactamase gene from a Pseudomonas aeruginosa clinical isolate. Antimicrob. Agents Chemother. 43:1584-1590. (Pubitemid 29331232)
25. Livermore, D. M. 2009. Has the era of untreatable infections arrived? J. Antimicrob. Chemother. 64(Suppl. 1):i29-i36.
26. Llarrull, L. I., S. A. Testero, J. F. Fisher, and S. Mobashery. 2010. The future of the beta-lactams. Curr. Opin. Microbiol. 13:551-557.
27. Materon, I. C., Z. Beharry, W. Huang, C. Perez, and T. Palzkill. 2004. Analysis of the context dependent sequence requirements of active site residues in the metallo-beta-lactamase IMP-1. J. Mol. Biol. 344:653-663. (Pubitemid 39469210)
28. Materon, I. C., and T. Palzkill. 2001. Identification of residues critical for metallo-beta-lactamase function by codon randomization and selection. Protein Sci. 10:2556-2565. (Pubitemid 33091580)
29. Merino, M., et al. 2010. Role of changes in the L3 loop of the active site in the evolution of enzymatic activity of VIM-type metallo-beta-lactamases. J. Antimicrob. Chemother. 65:1950-1954.
30. Neu, H. C., and L. A. Heppel. 1965. The release of enzymes from Escherichia coli by osmotic shock and during the formation of spheroplasts. J. Biol. Chem. 240:3685-3692.
31. Neuwald, A. F., J. S. Liu, D. J. Lipman, and C. E. Lawrence. 1997. Extracting protein alignment models from the sequence database. Nucleic Acids Res. 25:1665-1677. (Pubitemid 27303345)
32. Oelschlaeger, P., R. D. Schmid, and J. Pleiss. 2003. Insight into the mechanism of the IMP-1 metallo-beta-lactamase by molecular dynamics simulations. Protein Eng. 16:341-350. (Pubitemid 36806925)
33. Osano, E., et al. 1994. Molecular characterization of an enterobacterial metallo beta-lactamase found in a clinical isolate of Serratia marcescens that shows imipenem resistance. Antimicrob. Agents Chemother. 38:71-78. (Pubitemid 24018160)
34. Park, H., and K. M. Merz, Jr. 2005. Force field design and molecular dynamics simulations of the carbapenem- and cephamycin-resistant dinuclear zinc metallo-beta-lactamase from Bacteroides fragilis and its complex with a biphenyl tetrazole inhibitor. J. Med. Chem. 48:1630-1637. (Pubitemid 40364569)
35. Peracchi, A. 2001. Enzyme catalysis: removing chemically 'essential' residues by site-directed mutagenesis. Trends Biochem. Sci. 26:497-503. (Pubitemid 32735451)
36. Prosperi-Meys, C., J. Wouters, M. Galleni, and J. Lamotte-Brasseur. 2001. Substrate binding and catalytic mechanism of class B beta-lactamases: a molecular modelling study. Cell. Mol. Life Sci. 58:2136-2143. (Pubitemid 34016982)
37. Queenan, A. M., and K. Bush. 2007. Carbapenemases: the versatile betalactamases. Clin. Microbiol. Rev. 20:440-458.
38. Rudgers, G. W., W. Huang, and T. Palzkill. 2001. Binding properties of a peptide derived from beta-lactamase inhibitory protein. Antimicrob. Agents Chemother. 45:3279-3286. (Pubitemid 33107836)
39. Samuelsen, O., et al. 2010. Molecular epidemiology of metallo-beta-lactamase- producing Pseudomonas aeruginosa isolates from Norway and Sweden shows import of international clones and local clonal expansion. Antimicrob. Agents Chemother. 54:346-352.
40. Sharma, N. P., et al. 2006. Mechanistic studies on the mononuclear ZnIIcontaining metallo-beta-lactamase ImiS from Aeromonas sobria. Biochemistry 45:10729-10738. (Pubitemid 44320488)
41. Sideraki, V., W. Huang, T. Palzkill, and H. F. Gilbert. 2001. A secondary drug resistance mutation of TEM-1 beta-lactamase that suppresses misfolding and aggregation. Proc. Natl. Acad. Sci. U. S. A. 98:283-288. (Pubitemid 32095901)
42. Spencer, J., A. R. Clarke, and T. R. Walsh. 2001. Novel mechanism of hydrolysis of therapeutic beta-lactams by Stenotrophomonas maltophilia L1 metallo-beta-lactamase. J. Biol. Chem. 276:33638-33644.
43. Walsh, C. 2003. Antibiotics: actions, origins, resistance. ASM Press, Washington, DC.
44. Xu, D., D. Xie, and H. Guo. 2006. Catalytic mechanism of class B2 metallobeta- lactamase. J. Biol. Chem. 281:8740-8747.
45. Xu, D., Y. Zhou, D. Xie, and H. Guo. 2005. Antibiotic binding to monozinc CphA beta-lactamase from Aeromonas hydrophila: quantum mechanical/ molecular mechanical and density functional theory studies. J. Med. Chem. 48:6679-6689. (Pubitemid 41504724)
46. Yanchak, M. P., R. A. Taylor, and M. Crowder. 2000. Mutational analysis of metallo-β-lactamase CcrA from Bacteroides fragilis. Biochemistry 39:11330-11339.
47. Yong, D., et al. 2009. Characterization of a new metallo-beta-lactamase gene, blaNDM-1, and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob. Agents Chemother. 53:5046-5054.